Icon

JANUMET XR (nda202270)- (1GM;EQ 50MG BASE,1GM;EQ 100MG BASE,500MG;EQ 50MG BASE)

METFORMIN HYDROCHLORIDE; SITAGLIPTIN PHOSPHATE MSD SUB MERCK
1GM;EQ 50MG BASE,1GM;EQ 100MG BASE,500MG;EQ 50MG BASE
Yes No
2027-May-24 Expired
None None
None No
JANUMET XR is a dipeptidyl peptidase-4 (DPP-4) inhibitor and biguanide combination product indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus when treatment with both sitagliptin and metformin extended-release is appropriate.
0 2 0
Total Other Developers 55
Drugs with Suitability No
1GM;EQ 50MG BASE ** ** Up - -
1GM;EQ 100MG BASE ** ** Up - -
500MG;EQ 50MG BASE ** ** Up - -
NDA Sales Available Total Generic Sales Available
Yes 0
ANDA No Generic Co Manufacturer Name Operations Manufacturer Address Country

Download GenUS Drug Report


Download GenUS Detailed Report


To get detailed report Contact Us

GenUs Advanced Search




Expired
to
Expired
to


Brand Name Generic Name Strength Dosage Route of Administration Innovator ParaIV

Please contact contact@researchdelta.com to get more details.